Brinker Capital’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$2.02M Buy
19,107
+1,118
+6% +$115K 0.06% 297
2020
Q1
$1.61M Buy
17,989
+552
+3% +$52K 0.06% 286
2019
Q4
$1.74M Buy
17,437
+1,410
+9% +$133K 0.05% 352
2019
Q3
$1.43M Sell
16,027
-72
-0.4% -$6.24K 0.05% 390
2019
Q2
$1.33M Buy
16,099
+708
+5% +$55.5K 0.05% 388
2019
Q1
$1.25M Buy
15,391
+399
+3% +$31.4K 0.05% 387
2018
Q4
$1.14M Sell
14,992
-1,927
-11% -$150K 0.05% 363
2018
Q3
$1.34M Sell
16,919
-634
-4% -$48K 0.05% 406
2018
Q2
$1.23M Sell
17,553
-312
-2% -$22.4K 0.05% 418
2018
Q1
$1.25M Buy
17,865
+1,458
+9% +$101K 0.05% 409
2017
Q4
$1.14M Buy
16,407
+1,315
+9% +$88.7K 0.04% 390
2017
Q3
$1.02M Buy
15,092
+6,732
+81% +$425K 0.04% 404
2017
Q2
$570K Buy
8,360
+4,233
+103% +$276K 0.03% 490
2017
Q1
$257K Buy
+4,127
New +$240K 0.01% 827

Other funds holding AZN